Collectively, our study revealed that PSMB8 can not only be a useful prognostic factor in glioma patients, but also a predictive marker of prognostic factors and novel therapeutic target by blocking key proteins of TGF-β signaling. Here, TGFB1 is linked to central nervous system cancer.